Industry News
Pharmaceutical Industry News
Aerospace technology company…
Aerospace technology company Redwire—which has partnered with BMS and Eli Lilly to test drug development and manufacturing in space—has opened a new 30,000-square-foot research and microgravity payload development facility in Indiana.
Novartis’ CEO remains unfazed by…
Novartis' CEO remains unfazed by the threat of a newly approved oral PCSK9 inhibitor in Merck & Co.’s Lipfendra, doubling down on the long-term potential of his company's injectable cholesterol drug, Leqvio.
Novo Nordisk has accused Eli Lilly…
Novo Nordisk has accused Eli Lilly of running ad campaigns containing “deliberately false” messages that mislead the public about the comparative efficacy of GLP-1 medicines.
Detailed phase 3 results from two…
Detailed phase 3 results from two Islend clinical trials confirmed that a once-weekly, single-tablet combination of Merck’s islatravir and Gilead’s lenacapavir matches daily treatments like Biktarvy at maintaining HIV viral suppression
Johnson & Johnson and AbbVie…
Johnson & Johnson and AbbVie look set for a continued pharma ad spending battle for the second half of 2026 as the U.S. Big Pharma’s immunology drug Tremfya took the top spot for a second
The Healthcare Champion of the…
The Healthcare Champion of the Year, to be selected by J&J and a panel of industry experts, will be recognized at Time’s “A Year in TIME” celebration in December.
Widespread misconceptions about…
Widespread misconceptions about Type 1 diabetes could be contributing to a reluctance to get screened for the autoimmune disease, according to a survey Sanofi commissioned.
South Korean contract manufacturer…
South Korean contract manufacturer Samsung Biologics has tapped into the booming peptide production and weight loss market with plans to buy out Switzerland-based CDMO PolyPeptide for 1.46 billion Swiss francs ($1.8 billion).
On paper, it was another strong…
On paper, it was another strong quarter for Carvykti. Johnson & Johnson reported record sales for the CAR-T therapy, signaling robust demand in multiple myeloma. Yet record revenue wasn’t enough to spare its partner, Legend
The campaign is one of weight loss…
The campaign is one of weight loss app Noom's largest brand investments to date and features two TV spots and new in-app features with its chief wellness officer, Rebel Wilson.
The FDA has converted its…
The FDA has converted its accelerated approval for Novartis' Fabhalta into a full blessing to treat patients with immunoglobulin A nephropathy (IgAN). The drug is endorsed to slow kidney function decline in adults at risk
The FDA has converted its…
The FDA has converted its accelerated approval for Novartis' Fabhalta into a full blessing to treat patients with immunoglobulin A nephropathy (IgAN). The drug is endorsed to slow kidney function decline in adults at risk
From Indiana to Iceland, the FDA…
From Indiana to Iceland, the FDA this week disclosed concerns raised during recent visits to a pair of manufacturing sites with troubled regulatory histories.
From Indiana to Iceland, the FDA…
From Indiana to Iceland, the FDA this week disclosed concerns raised during recent visits to a pair of manufacturing sites with troubled regulatory histories.
ADCs from Kelun-Biotech and Hansoh…
ADCs from Kelun-Biotech and Hansoh Pharma, respectively partnered with Merck and GSK, delivered positive phase 3 readouts. AstraZeneca reached out to its spinout Dizal for an EGFR lung cancer med. Biotechs are growing protective of
ADCs from Kelun-Biotech and Hansoh…
ADCs from Kelun-Biotech and Hansoh Pharma, respectively partnered with Merck and GSK, delivered positive phase 3 readouts. AstraZeneca reached out to its spinout Dizal for an EGFR lung cancer med. Biotechs are growing protective of
Foundation Medicine has started…
Foundation Medicine has started the “Quality First” initiative to create awareness of how “not all cancer biomarker tests are created equal.”
In the past six years, the…
In the past six years, the pharmaceutical industry has sought to show itself to the world more than ever before. The COVID-19 pandemic brought these companies into the spotlight and, rather than shy away, many
What to Know About the New Cholesterol Pill and How it Compares to Statins
How does it compare to statins? Should you take it? And how much does it cost?
CG Life and its rare disease…
CG Life and its rare disease awareness platform 24/364 will host a first-of-its-kind rare disease film festival in San Diego next March featuring documentaries exploring the lived experience of patients with rare diseases.